Hehir Invested as James F. Howard Jr. Professor in Neuromuscular Disorders
|
In a formal ceremony held January 26, Professor of Neurological Sciences Michael Hehir, M.D., was invested as the inaugural holder of the James F. Howard Jr. Professorship in Neuromuscular Disorders. This endowed professorship was established through the generosity of James F. Howard Jr., M.D.’74, and his wife, School of Nursing alum Adrienne (Brown) Howard ’75. The professorship supports clinical research in myasthenia gravis.
|
|
|
|
On January 24, the Larner College of Medicine held its annual Foundations Awards Celebration for the Class of 2026. The celebration not only acknow- ledges the completion of Foundations—the inaugural stage of the Vermont Integrated Curriculum—but also pays tribute to the students’ achievements and the dedicated teachers and staff who have guided them.
|
|
|
| Cancer Therapy Enters Phase 2
|
A promising anti-cancer treatment under investigation by the Cunniff Lab at the UVM Cancer Center and transitioned to clinical testing by RS Oncology has entered Phase 2 trials. RSO-021 is a new therapy for mesothelioma, an aggressive cancer linked to occupational asbestos exposure with a five-year survival rate of only 5 to 10 percent.
|
|
|
| Healing Through the Humanities |
The fusion of humanities and medicine is invaluable for health care professionals. By embracing diverse art forms, practitioners gain profound insights into the human experience. This synergy was evident at Larner College of Medicine’s inaugural Humanities in Medicine event, held on February 6, featuring local artist Mary Lacy.
|
|
|
| “I found myself volunteering in many youth programs throughout my life so far and each interaction has given me hope for the future.” —Shubi Joshi, Class of 2025
“I loved the idea of bringing our Vermont and Connecticut communities together in a way that highlighted our commitment to service and sneakers.” —Mohamad Hamze, Class of 2024
|
|
|
ACCOLADES & ACCOMPLISHMENTS
|
|
|
| A proposal by Professor Emeritus of Biochemistry and Microbiology and Molecular Genetics Scott Morrical, Ph.D., on the cyano-bacteriophage-encoded glucose-6-phosphate dehydrogenase enzyme was recently selected for funding by the UVM Retired Scholars Award Program. The program aims to support retired faculty members in pursuing research or scholarly projects post-retirement.
|
|
|
| Nimrat Chatterjee, M.Sc., Ph.D., Cancer Center member and assistant professor of microbiology and molecular genetics, has been honored with a prestigious Maximizing Investigators’ Research Award (MIRA, or R35) from the National Institute of General Medical Sciences. The five-year $1.9 million grant will support Chatterjee’s work studying DNA damage and mutagenic repair responses.
|
|
|
| In a report in Nature Medicine, Cancer Center Member and Assistant Professor of Medicine James Gerson, M.D.
, and colleagues address questions about T-cell lymphomas in patients treated with CAR T-cell therapy. The researchers found that the risk of T-cell lymphomas following CAR T-cell therapy is minute, suggesting that the risk-benefit analysis for this potentially lifesaving therapy favors the positive benefit it can have on patients’ lives.
|
|
|
| Assistant Professor of Psychiatry Elias Klemperer, Ph.D., was recently awarded his first R01 grant
—a combined award from the Food and Drug Administration Center for Tobacco Products and the National Institute on Drug Abuse—to further study nicotine-limiting standards for cigarettes and e-cigarettes among adults in Rhode Island, Vermont, and Northern New York State.
|
|
|
| Professor of Psychiatry Julie Dumas, Ph.D., and C. Lawrence Kien, M.D., Ph.D., Mary Kay Davignon Green and Gold Professor Emeritus of Pediatrics and Medicine, have recently secured a $3.3M, five-year R01 grant from the National Institute on Aging for “Fatty Acid Modulation of Brain Functioning in Older Adults.” This award will enable the duo to delve deeper into the relationship between dietary fatty acids and cognitive health in older individuals.
|
|
|
| Applications for the Teaching Academy’s 2024 Frymoyer Scholars Program are due by March 1, 2024
. Individuals selected as Frymoyer Scholars are awarded up to $25,000 per year for two years to develop innovative educational products or programs and/or to improve their teaching skills. Details about the program, eligibility, and how to apply are available here.
|
|
|
| The Office of Diversity, Equity, and Inclusion at the Larner College of Medicine will host the fifth annual Celebration of Gender Equity in Medicine and Science on March 7, 12–1:30 p.m.
, in the Sullivan Classroom (MedEd Center 200). This inspiring event offers insight into the critical role of data in gender equity advocacy and includes awards in recognition of gender equity leaders from across the college community.
|
|
|
Amiri L, Ross W. Reducing Barriers and Improving Motivations of Students Enrolled in Summer Health Professions Exposure Programs. JAMA Netw Open. 2024;7(1):e2352426. doi:10.1001/jamanetworkopen.2023.52426.
Ayer, L., Ohana, E., Ivanova, M. Y., Frering, H. E., Achenbach, T. M., & Althoff, R. R. (2024). Emotional and Behavioral Problem Profiles of Preteens With Self-Injurious Thoughts and Behaviors: A Multicultural Study. Journal of the American Academy of Child & Adolescent Psychiatry. DOI: 10.1016/j.jaac.2023.11.012.
Banks, Erika MD; Winkel, Abigail F. MD; Morgan, Helen K. MD; Connolly, AnnaMarie MD; Hammoud, Maya M. MD, MBA; George, Karen E. MD, MPH. Program Signaling in Obstetrics and Gynecology Residency Applications. Obstetrics & Gynecology 143(2):p 281-283, February 2024. DOI: 10.1097/AOG.0000000000005470.
Findlay MC, Sarriera-Valentin G, Earl ER, Cole KL, Hamrick FA, Baradaran H, Cortez J, Lombardo S, Nunez J, Kilburg C, Grandhi R, Menacho ST. Management Patterns and Outcomes After Traumatic Brain Injury With Associated Blunt Cerebrovascular Injury. Neurosurgery. 2024 Feb 1;94(2):340-349. doi: 10.1227/neu.0000000000002688. Epub 2023 Sep 18. PMID: 37721436.
Hammoud MM, Morgan HK, George K, Ollendorff AT, Dalrymple JL, Dunleavy D, Zhu M, Banks E, Akingbola BA, Connolly A. Trends in Obstetrics and Gynecology Residency Applications in the Year After Abortion Access Changes. JAMA Netw Open. 2024 Feb 5;7(2):e2355017. doi: 10.1001/jamanetworkopen.2023.55017. PMID: 38324311.
Keene K, Balasubramanian A, Potter A, Cioffredi LA. Maternal worry of children contracting COVID-19 predicts vaccine uptake in young children in Vermont. Vaccine X. 2024 Jan 19;16:100442. doi: 10.1016/j.jvacx.2024.100442. PMID: 38318233; PMCID: PMC10839441.
Myers, A.J., Potts, C., Makarewicz, J.A., McGee, E., & Dumas, J.A. (2023). Choline kinase alpha genotype is related to hippocampal brain volume and cognition in postmenopausal women. Helyion, Dec 22;10(1):e23963. doi: 10.1016/j.heliyon.2023.e23963. eCollection 2024 Jan 15.
Palermo BJ, Wilkinson KS, Plante TB, Nicoli CD, Judd SE, Kamin Mukaz D, Long DL, Olson NC, Cushman M. Interleukin-6, Diabetes, and Metabolic Syndrome in a Biracial Cohort: The Reasons for Geographic and Racial Differences in Stroke Cohort. Diabetes Care. 2024 Jan 18:dc230914. doi: 10.2337/dc23-0914. Epub ahead of print. PMID: 38237104.
Ross EL, Bossarte RM, Dobscha SK, Gildea SM, Hwang I, Kennedy CJ, Liu H, Luedtke A, Marx BP, Nock MK, Petukhova MV, Sampson NA, Zainal NH, Sverdrup E, Wager S, Kessler RC. Estimated Average Treatment Effect of Psychiatric Hospitalization in Patients With Suicidal Behaviors: A Precision Treatment Analysis
. JAMA Psychiatry. 2024 Feb 1;81(2):135-143. doi: 10.1001/jamapsychiatry.2023.3994. PMID: 37851457; PMCID: PMC10585585.
Volaric AK. Establishing sustainable collaborations in global pathology education. Front Med (Lausanne). 2023 Dec 21;10:1346780. doi: 10.3389/fmed.2023.1346780. PMID: 38179274; PMCID: PMC10764422.
Walsh MR, Alam MS, Pierce KK, Carmolli M, Alam M, Dickson DM, Bak DM, Afreen S, Nazib F, Golam K, Qadri F, Diehl SA, Durbin AP, Whitehead SS, Haque R, Kirkpatrick BD. Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial
. Lancet Infect Dis. 2024 Feb;24(2):150-160. doi: 10.1016/S1473-3099(23)00520-0. Epub 2023 Sep 27. PMID: 37776876.
Zakai NA, Wilkinson K, Sparks AD, Packer RT, Koh I, Roetker NS, Repp AB, Thomas R, Holmes CE, Cushman M, Plante TB, Al-Samkari H, Pishko AM, Wood WA, Masias C, Gangaraju R, Li A, Garcia D, Wiggins KL, Schaefer JK, Hooper C, Smith NL, McClure LA.
Development and validation of a risk model for hospital-acquired venous thrombosis: the Medical Inpatients Thrombosis and Hemostasis study. J Thromb Haemost. 2024 Feb;22(2):503-515. doi: 10.1016/j.jtha.2023.10.015. Epub 2023 Oct 31. PMID: 37918635.
|
|
|
WE WANT TO HEAR FROM YOU!
|
|
|
UVM LARNER COLLEGE OF MEDICINE
|
Published by the Office of Medical Communications © 2024
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
Given Building 89 Beaumont Ave | Burlington, VT 05405 US
|
|
| This email was sent to marian.e.miller@med.uvm.edu.
To continue receiving our emails, add us to your address book.
|
|
|
|
